Table 4 Recovery time length association with early/late/no drug use
Drug use | Beta (95% CI) | P-value | |
|---|---|---|---|
Arbidol | Early use vs No use | − 5.2 (− 7.5, − 3.0) | 4.0E−06 |
Late use vs No use | 1.4 (− 0.1, 2.9) | 0.074 | |
Overall use vs No use | − 0.1 (− 1.8, 1.6) | 0.91 | |
Ribavirin | Early use vs No use | − 0.3 (− 2.2, 1.59) | 0.75 |
Late use vs No use | 3.0 (1.1, 4.8) | 0.0018 | |
Overall use vs No use | 2.1 (0.5, 3.7) | 0.01 | |
IFN-α | Early use vs No use | − 0.2 (− 2.0, 1.6) | 0.82 |
Late use vs No use | 2.2 (− 0.1, 4.4) | 0.06 | |
Overall use vs No use | 1.4 (− 0.6, 3.4) | 0.17 | |
Lopinavir–ritonavir | Early use vs No use | 4.7 (3.1, 6.2) | 1.8E−08 |
Late use vs No use | 7.5 (5.4, 9.6) | 1.7E−11 | |
Overall use vs No use | 4.1 (2.3, 5.9) | 1.4E−05 |